M. Caratan, Inc. – Trademark Portfolio
Entity Type: 03
M. Caratan, Inc. holds 24 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 31 (Natural Agricultural Products) — 19 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 3 Nice Classification classes. Currently, 6 trademarks are registered. Notable registered marks include LAUREL, MILANO, HOLIDAY, OLYMPIC, and ANTHURIUM. The owner is based in Delano, CA.
33787 Cecil Avenue
Delano, CA 93215
Showing of trademarks Trademarks
Trademark Classifications
M. Caratan, Inc.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Raw and unprocessed agricultural, aquacultural, horticultural and forestry products
Advertising; business management; business administration; office functions
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does M. Caratan, Inc. have?
M. Caratan, Inc. has 24 U.S. trademarks filed with the USPTO. Of these, 6 registered, 10 abandoned, 8 cancelled.
What trademark classes does M. Caratan, Inc. file in?
M. Caratan, Inc. files trademarks across 3 Nice Classification classes. The most active classes are Class 31 (Natural Agricultural Products), Class 35 (Advertising & Business), Class 44 (Medical Services). Class 31 covers raw and unprocessed agricultural, aquacultural, horticultural and forestry products.
What are M. Caratan, Inc.'s most well-known trademarks?
M. Caratan, Inc.'s registered trademark portfolio includes well-known marks such as LAUREL, MILANO, HOLIDAY, OLYMPIC, and ANTHURIUM. These are among 6 currently registered trademarks in the portfolio.
What is M. Caratan, Inc.'s trademark registration success rate?
M. Caratan, Inc. has a 25% trademark registration rate, with 6 out of 24 resolved applications resulting in successful registration. Currently, 0 applications are pending review.